Press Releases


IXICO to Present Tau PET Imaging Research at Human Amyloid Imaging Conference

IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, today announces it has  partnered with the Human Amyloid Imaging Conference (15-17 January 2020, Miami, USA) as a Bronze Sponsor and will be presenting scientific posters highlighting its latest methodology advances in Tau Positron Emission Tomography (PET) and Amyloid PET imaging to...

Read more

IXICO announces updates to client contracts

£2. 4 million expansion of study programmes with two large pharma client contracts IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, today announces: c£1. 8 million extension to a Phase III study in Huntington's Disease (HD), previously announced in September 2018 c£0.

Read more

IXICO Releases 2019 Annual Report and Notice of AGM

IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, confirms that the Annual Report and Accounts for the year ended 30 September 2019 ("Annual Report and Accounts 2019") and the Notice of Annual General Meeting ("AGM") have been posted to shareholders on 12 December and 16 December, respectively.

Read more

IXICO Releases Financial Results for the year ended 30 September 2019

First profitable full year built upon increased penetration of growing market combined with operational leverage   IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, today announces its final results for the year ended 30 September 2019.

Read more

IXICO to Present Latest Research at Upcoming Clinical Trials on Alzheimer's Disease Congress

IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience clinical drug development, today announces that it is scheduled to attend and present scientific posters at the 2019 Clinical Trials on Alzheimer's Disease (CTAD) Congress held from 4th-7th December 2019 in San Diego, California, USA.

Read more

IXICO to Present Latest Research at Upcoming Huntington's Disease and Ataxia Conferences

IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, today announces that it is scheduled to attend and present scientific posters at the following conferences in November 2019.

Read more

IXICO to Present at 10th Annual CNS Summit 2019

IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, today announces that it is scheduled to attend and present at the 10th Annual CNS Summit held from 31st October to 3rd November 2019 in Boca Raton, Florida, USA.

Read more

IXICO announces client contracts and appointment of Chief Business Officer

 IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, today announces three new biopharma contracts and the appointment of Lammert Albers as Chief Business Officer effective immediately.

Read more